| Mary Latoche, MS, CCC-SLP | |
|
5520 Broadview Rd Frnt, Parma, OH 44134-1605 | |
| (216) 749-6650 | |
| (216) 749-1655 |
| Full Name | Mary Latoche |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5520 Broadview Rd Frnt, Parma, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114327939 | NPI | - | NPPES |
| 000000603852 | Other | OH | ANTHEM BLUE CROSS AND BLUE SHIELD |
| 12763285 | Other | OH | CAQH |
| 0113587 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP.10035 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Latoche, MS, CCC-SLP 5000 Rockside Rd Ste 500, Independence, OH 44131-2178 Ph: (216) 459-2846 | Mary Latoche, MS, CCC-SLP 5520 Broadview Rd Frnt, Parma, OH 44134-1605 Ph: (216) 749-6650 |
News Archive
New research by Jeff Geschwind, M.D., director of interventional radiology and associate professor at Johns Hopkins University School of Medicine, has shown that liver cancer patients, most of whom have inoperable tumours, could benefit from chemoembolization, a nonsurgical treatment option that delivers a high-dose of chemotherapy to the tumour while decreasing blood flow through the arteries feeding the tumour, known as embolization.
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.
Use of the weight-loss medication rimonabant produced modest yet sustained weight loss after 2 years, and improved HDL cholesterol and triglyceride levels, according to a study in the February 15 issue of JAMA: The Journal of the American Medical Association.
Schering-Plough Corporation (NYSE: SGP) today announced an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. ("Orchid"), related to the generic manufacturing of certain formulations of CLARINEX(R) (desloratadine).
Women and men often show marked differences as regards mental illnesses. In order to learn more about this phenomenon, a project supported by the Austrian Science Fund FWF explored how opposite-sex hormonal therapy applied to transgender individuals influences the brain.
› Verified 9 days ago
Mrs. Sarah Jane Ingle, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-885-8308 | |
Kristy Marie Lantz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4040 Tamarack Dr, Parma, OH 44134 Phone: 440-572-1337 | |
Vanessa Mary Spring, MED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-885-5300 | |
Mrs. Michelle Dawn Miller, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 Broadview Rd, Parma, OH 44134 Phone: 812-243-6611 | |
Mrs. Anne Cary, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6149 W 130th St, Parma, OH 44130 Phone: 216-344-1546 | |
Alexandra Schiefferle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-842-5300 Fax: 440-885-8304 | |
Debra Stibora, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7700 Malibu Dr, Parma, OH 44130 Phone: 440-885-8645 |